We are live on
!
Find out more
ACM
Americafirst Capital Management Portfolio holdings
AUM
$74M
1-Year Est. Return
13.49%
This Fund
S&P 500
This Quarter
Est. Return
+0.27%
1 Year Est. Return
+13.49%
3 Year Est. Return
+32.9%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$186M
AUM Growth
-$15.8M
(-7.8%)
Cap. Flow
-$57.9M
Cap. Flow
% of AUM
-31.23%
Top 10 Holdings %
Top 10 Hldgs %
13.44%
Holding
339
New
70
Increased
17
Reduced
42
Closed
146
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1.12M |
| 2 |
Bunge Global
BG
|
+$1.08M |
| 3 |
Coty
COTY
|
+$1.07M |
| 4 |
SCLN
Sciclone Pharmaceuticals Inc
SCLN
|
+$1.03M |
| 5 |
IQVIA
IQV
|
+$1.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$5.45M |
| 2 |
Invesco DB US Dollar Index Bullish Fund
UUP
|
+$5.44M |
| 3 |
HCA Healthcare
HCA
|
+$2.05M |
| 4 |
VeriSign
VRSN
|
+$1.7M |
| 5 |
Quest Diagnostics
DGX
|
+$1.66M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.83% |
| 2 | Consumer Staples | 12.34% |
| 3 | Utilities | 5.94% |
| 4 | Financials | 4.71% |
| 5 | Consumer Discretionary | 3.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Ingles Markets
IMKTA
$1.72B
| $3.13M | 1.69% |
65,433
+9,598
| +17% | +$463K |
|
2
United Therapeutics
UTHR
$26.1B
| $3.01M | 1.62% |
17,327
+1,601
| +10% | +$288K |
|
3
Cigna
CI
$78.4B
| $2.5M | 1.35% |
15,437
-4,672
| -23% | -$645K |
|
4
Public Service Enterprise Group
PEG
$38.7B
| $2.46M | 1.32% |
62,545
+14,358
| +30% | +$596K |
|
|
SAFM
5
DELISTED
Sanderson Farms Inc
SAFM
| $2.41M | 1.3% |
32,073
-11,899
| -27% | -$944K |
|
|
AET
6
DELISTED
Aetna Inc
AET
| $2.28M | 1.23% |
17,900
-4,838
| -21% | -$552K |
|
7
Entergy
ETR
$50.3B
| $2.21M | 1.19% |
62,812
+14,480
| +30% | +$544K |
|
8
Monster Beverage
MNST
$95.1B
| $2.19M | 1.18% |
97,872
-24,600
| -20% | -$549K |
|
9
Molina Healthcare
MOH
$10.4B
| $2.16M | 1.16% |
30,709
-8,225
| -21% | -$550K |
|
10
Pilgrim's Pride
PPC
$7.13B
| $2.14M | 1.15% |
93,193
-20,538
| -18% | -$508K |
|
|
CVGW
11
DELISTED
Calavo Growers
CVGW
| $2.09M | 1.12% |
40,178
-9,718
| -19% | -$506K |
|
12
Elevance Health
ELV
$81.5B
| $2.06M | 1.11% |
12,542
-3,450
| -22% | -$551K |
|
|
13
HCA Healthcare
HCA
$88.4B
| $2M | 1.08% |
22,070
-25,588
| -54% | -$2.05M |
|
|
LPNT
14
DELISTED
LifePoint Health, Inc.
LPNT
| $1.98M | 1.07% |
22,824
-5,672
| -20% | -$429K |
|
|
RAD
15
DELISTED
Rite Aid Corporation
RAD
| $1.97M | 1.06% |
11,780
-3,010
| -20% | -$505K |
|
|
LNCE
16
DELISTED
Snyders-Lance, Inc.
LNCE
| $1.95M | 1.05% |
60,341
-14,728
| -20% | -$454K |
|
|
HNT
17
DELISTED
HEALTH NET INC
HNT
| $1.94M | 1.04% |
30,179
-8,048
| -21% | -$481K |
|
|
MDAS
18
DELISTED
MEDASSETS INC COM STK (DE)
MDAS
| $1.84M | 0.99% |
83,345
-20,024
| -19% | -$418K |
|
|
PRXL
19
DELISTED
Parexel International Corp
PRXL
| $1.83M | 0.99% |
28,477
-7,101
| -20% | -$478K |
|
20
Edwards Lifesciences
EW
$49.4B
| $1.8M | 0.97% |
75,630
-18,678
| -20% | -$422K |
|
21
Labcorp
LH
$25.2B
| $1.72M | 0.93% |
16,544
-4,015
| -20% | -$418K |
|
22
Archer Daniels Midland
ADM
$38.7B
| $1.7M | 0.92% |
35,222
-8,839
| -20% | -$446K |
|
|
ESRX
23
DELISTED
Express Scripts Holding Company
ESRX
| $1.7M | 0.91% |
19,072
-4,715
| -20% | -$412K |
|
|
BCR
24
DELISTED
CR Bard Inc.
BCR
| $1.65M | 0.89% |
9,655
-2,372
| -20% | -$405K |
|
|
25
Invesco DB US Dollar Index Bullish Fund
UUP
$423M
| $1.6M | 0.86% |
63,737
-215,657
| -77% | -$5.44M |
|
Similar funds
VE
GFWEV
TLIC
FO
CD
MC
FIM
MKCM
Americafirst Capital Management's Q2 2015 Portfolio in Review
As of Q2 2015, Americafirst Capital Management held 339 positions worth $186M, down 7.8% from $201M the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Americafirst Capital Management withdrew a net $57.9M in Q2 2015, closing 146 positions and reducing 42 holdings. Its most notable exit was VeriSign, an estimated $1.7M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Consumer Staples and Utilities.
Against the trend, Americafirst Capital Management opened a new position in Gilead Sciences worth $1.2M.
- Americafirst Capital Management's largest Q2 2015 buy was Gilead Sciences: 10,224 shares worth $1.2M.
- Americafirst Capital Management added most to OUTERWALL INC in Q2 2015, an estimated $791K increase.
- Americafirst Capital Management's biggest Q2 2015 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $5.45M.
- Americafirst Capital Management fully exited VeriSign in Q2 2015, selling an estimated $1.7M.
- Americafirst Capital Management's ten largest holdings make up 13% of its $186M portfolio in Q2 2015.
- Americafirst Capital Management opened 70 new positions and closed 146 in Q2 2015.
- Americafirst Capital Management's portfolio value fell 7.8% quarter-over-quarter to $186M.
Based on Americafirst Capital Management's 13F filing for Q2 2015, filed 27 Jul 2015.